Page 369 - Avian Virology: Current Research and Future Trends

360 | Lupiani et al.
Bulow, V.V., and Biggs, P.M. (1975b). Precipitating antigens associated with Davison, A.J., Eberle, R., Ehlers, B., Hayward, G.S., McGeoch, D.J., Minson,
Marek’s disease viruses and a herpesvirus of turkeys. Avian Pathol. 4, A.C., Pellett, P.E., Roizman, B., Studdert, M.J., and Thiry, E. (2009).
147–162. The order Herpesvirales. Arch. Virol. 154, 171–177. https://doi.
Burnside, J., Bernberg, E., Anderson, A., Lu, C., Meyers, B.C., Green, P.J., Jain, org/10.1007/s00705-008-0278-4.
N., Isaacs, G., and Morgan, R.W. (2006). Marek’s disease virus encodes Davison, F., and Nair, V. (2005). Use of Marek’s disease vaccines: could
MicroRNAs that map to meq and the latency-associated transcript. J. they be driving the virus to increasing virulence? Expert Rev. Vaccines
Virol. 80, 8778–8786. 4, 77–88.
Calnek, B.W. (1986). Marek’s disease – a model for herpesvirus oncology. Denesvre, C. (2013). Marek’s disease virus morphogenesis. Avian Dis.
Crit. Rev. Microbiol. 12, 293–320. 57 (Suppl. 2), 340–350. https://doi.org/10.1637/10375-09161
Calnek, B.W. (2001). Pathogenesis of Marek’s disease virus infection. Curr. 2-Review.1.
Top. Microbiol. Immunol. 255, 25–55. Deng, X., Li, X., Shen, Y., Qiu, Y., Shi, Z., Shao, D., Jin, Y., Chen, H., Ding,
Calnek, B.W., Adldinger, H.K., and Kahn, D.E. (1970a). Feather follicle C., Li, L., et al. (2010). The Meq oncoprotein of Marek’s disease virus
epithelium: a source of enveloped and infectious cell-free herpesvirus interacts with p53 and inhibits its transcriptional and apoptotic activities.
from Marek’s disease. Avian Dis. 14, 219–233. Virol. J. 7, 348. https://doi.org/10.1186/1743-422X-7-348.
Calnek, B.W., Hitchner, S.B., and Adldinger, H.K. (1970b). Lyophilization Ding, J., Cui, Z., Jiang, S., and Li, Y. (2008). Study on the structure of
of cell-free Marek’s disease herpesvirus and a herpesvirus from turkeys. heteropolymer pp38/pp24 and its enhancement on the bi-directional
Appl. Microbiol. 20, 723–726. promoter upstream of pp38 gene in Marek’s disease virus. Sci. China, C,
Camp, H.S., Coussens, P.M., and Silva, R.F. (1991). Cloning, sequencing, Life Sci. 51, 821–826. https://doi.org/10.1007/s11427-008-0099-4.
and functional analysis of a Marek’s disease virus origin of DNA Dunn, J.R., and Gimeno, I.M. (2013). Current status of Marek’s disease
replication. J. Virol. 65, 6320–6324. in the United States and worldwide based on a questionnaire
Cantello, J.L., Parcells, M.S., Anderson, A.S., and Morgan, R.W. (1997). survey. Avian Dis. 57 (Suppl. 2), 483–490. https://doi.
Marek’s disease virus latency-associated transcripts belong to a family of org/10.1637/10373-091412-ResNote.1.
spliced RNAs that are antisense to the ICP4 homolog gene. J. Virol. 71, Dunn, J.R., and Silva, R.F. (2012). Ability of MEQ-deleted MDV vaccine
1353–1361. candidates to adversely affect lymphoid organs and chicken weight gain.
Chi, X.J., Lu, Y.X., Zhao, P., Li, C.G., Wang, X.J., and Wang, M. (2013). Avian Dis. 56, 494–500. https://doi.org/10.1637/10062-011812-Reg.1.
Interaction domain of glycoproteins gB and gH of Marek’s disease virus El Kasmi, I., and Lippé, R. (2015). Herpes simplex virus 1 gN partners with
and identification of an antiviral peptide with dual functions. PLOS gM to modulate the viral fusion machinery. J. Virol. 89, 2313–2323.
ONE 8, e54761. https://doi.org/10.1371/journal.pone.0054761. https://doi.org/10.1128/JVI.03041-14.
Churchill, A.E., Payne, L.N., and Chubb, R.C. (1969). Immunization against Endoh, D. (1996). Enhancement of gene expression by Marek’s disease
Marek’s disease using a live attenuated virus. Nature 221, 744–747. virus homologue of the herpes simplex virus-1 ICP4. Jpn. J. Vet. Res. 44,
Coen, D.M., Kosz-Vnenchak, M., Jacobson, J.G., Leib, D.A., Bogard, 136–137.
C.L., Schaffer, P.A., Tyler, K.L., and Knipe, D.M. (1989). Thymidine Engel, A.T., Selvaraj, R.K., Kamil, J.P., Osterrieder, N., and Kaufer, B.B.
kinase-negative herpes simplex virus mutants establish latency in mouse (2012). Marek’s disease viral interleukin-8 promotes lymphoma
trigeminal ganglia but do not reactivate. Proc. Natl. Acad. Sci. U.S.A. 86, formation through targeted recruitment of B cells and CD4+ CD25+
4736–4740. T-cells. J. Virol. 86, 8536–8545. https://doi.org/10.1128/JVI.00556-12.
Cohen, J.I., and Seidel, K.E. (1993). Generation of varicella-zoster virus Faiz, N.M., Cortes, A.L., Guy, J.S., Fletcher, O.J., West, M., Montiel, E., and
(VZV) and viral mutants from cosmid DNAs: VZV thymidylate Gimeno, I.M. (2016). Early infection with Marek’s disease virus can
synthetase is not essential for replication in vitro. Proc. Natl. Acad. Sci. jeopardize protection conferred by laryngotracheitis vaccines: a method
U.S.A. 90, 7376–7380. to study MDV-induced immunosuppression. Avian Pathol. 45, 606–615.
Connolly, S.A., Jackson, J.O., Jardetzky, T.S., and Longnecker, R. (2011). Fragnet, L., Kut, E., and Rasschaert, D. (2005). Comparative functional
Fusing structure and function: a structural view of the herpesvirus entry study of the viral telomerase RNA based on natural mutations. J. Biol.
machinery. Nat. Rev. Microbiol. 9, 369–381. https://doi.org/10.1038/ Chem. 280, 23502–23515.
nrmicro2548. Friborg, J., Kong, W., Hottiger, M.O., and Nabel, G.J. (1999). p53 inhibition
Cortes, A.L., Montiel, E.R., and Gimeno, I.M. (2009). Validation of Marek’s by the LANA protein of KSHV protects against cell death. Nature 402,
disease diagnosis and monitoring of Marek’s disease vaccines from 889–894. https://doi.org/10.1038/47266.
samples collected in FTA cards. Avian Dis. 53, 510–516. https://doi. Friedberg, E.C., Walker, G.C., Siede, W., and Wood, R.D. (2005). DNA
org/10.1637/8871-041009-Reg.1. repair and mutagenesis (American Society for Microbiology Press,
Cortes, A.L., Montiel, E.R., Lemiere, S., and Gimeno, I.M. (2011). Washington, D.C.).
Comparison of blood and feather pulp samples for the diagnosis of Friedman, H.M., Cohen, G.H., Eisenberg, R.J., Seidel, C.A., and Cines, D.B.
Marek’s disease and for monitoring Marek’s disease vaccination by (1984). Glycoprotein C of herpes simplex virus 1 acts as a receptor for
real time-PCR. Avian Dis. 55, 302–310. https://doi.org/10.1637/957 the C3b complement component on infected cells. Nature 309, 633–635.
8-101510-ResNote.1. Fuchs, W., Klupp, B.G., Granzow, H., Osterrieder, N., and Mettenleiter, T.C.
Croce, C.M. (2009). Causes and consequences of microRNA dysregulation (2002). The interacting UL31 and UL34 gene products of pseudorabies
in cancer. Nat. Rev. Genet. 10, 704–714. https://doi.org/10.1038/ virus are involved in egress from the host-cell nucleus and represent
nrg2634. components of primary enveloped but not mature virions. J. Virol. 76,
Cui, H., Gao, H., Cui, X., Zhao, Y., Shi, X., Li, Q., Yan, S., Gao, M., Wang, 364–378.
M., Liu, C., et al. (2013). Avirulent Marek’s disease virus type 1 Gandon, S., Mackinnon, M.J., Nee, S., and Read, A.F. (2001). Imperfect
strain 814 vectored vaccine expressing avian influenza (AI) virus H5 vaccines and the evolution of pathogen virulence. Nature 414, 751–756.
haemagglutinin induced better protection than turkey herpesvirus https://doi.org/10.1038/414751a.
vectored AI vaccine. PLOS ONE 8, e53340. Gimeno, I.M. (2008). Marek’s disease vaccines: a solution for today but a
Cui, Z.Z., Lee, L.F., Liu, J.L., and Kung, H.J. (1991). Structural analysis and worry for tomorrow? Vaccine 26 (Suppl. 3), C31–41.
transcriptional mapping of the Marek’s disease virus gene encoding pp38, Gimeno, I.M., Witter, R.L., Hunt, H.D., Lee, L.F., Reddy, S.M., and
an antigen associated with transformed cells. J. Virol. 65, 6509–6515. Neumann, U. (2001). Marek’s disease virus infection in the brain: virus
Cunningham, C., and Davison, A.J. (1993). A cosmid-based system for replication, cellular infiltration, and major histocompatibility complex
constructing mutants of herpes simplex virus type 1. Virology 197, antigen expression. Vet. Pathol. 38, 491–503. https://doi.org/10.1354/
116–124. vp.38-5-491.
Darteil, R., Bublot, M., Laplace, E., Bouquet, J.F., Audonnet, J.C., and Rivière, Gimeno, I.M., Witter, R.L., Fadly, A.M., and Silva, R.F. (2005a). Novel
M. (1995). Herpesvirus of turkey recombinant viruses expressing criteria for the diagnosis of Marek’s disease virus-induced lymphomas.
infectious bursal disease virus (IBDV) VP2 immunogen induce Avian Pathol. 34, 332–340.
protection against an IBDV virulent challenge in chickens. Virology 211, Gimeno, I.M., Witter, R.L., Hunt, H.D., Reddy, S.M., Lee, L.F., and Silva, R.F.
481–490. (2005b). The pp38 gene of Marek’s disease virus (MDV) is necessary